Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06777368 · ClinicalTrials.gov registry record
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
A clinical trial of Aortic Stenosis, sponsored by Medtronic Cardiovascular.
- Recruiting
- Registry status
- 225
- Enrollment target
- 20
- Study locations
NCT06777368 is a study of Aortic Stenosis that is actively recruiting participants, run by Medtronic Cardiovascular. The registered enrollment target is 225 participants, below the 1,354-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT06777368, a study of Aortic Stenosis, is actively recruiting participants, sponsored by Medtronic Cardiovascular.
- RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Conditions Studied
Interventions
- DEVICE Medtronic TAV
- DEVICE Edwards TAV
Study Locations (20)
California
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- Sutter Heatlh - Sacramento
- Kaiser Permanente Northern California - Sacramento
- Stanford Hospital & Clinics - Stanford
- Los Robles Regional Medical Center - Thousand Oaks
Florida
- Morton Plant Hospital - Clearwater
- HealthPark Medical Center, Lee Memorial Health - Fort Myers
- Orlando Health/Orlando Regional Medical Center - Orlando
- Tampa General/USF - Tampa
Arizona
- Abrazo Arizona Heart Hospital - Phoenix
- Tucson Medical Center - Tucson
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Haven
Indiana
- Parkview Health - Fort Wayne
- Saint Vincent Heart Center of Indiana - Indianapolis
Iowa
- MercyOne Iowa Heart Center - Des Moines
- University of Iowa Hospitals and Clinics - Iowa City
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- Medical Center of the Rockies - Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2025-02-06 |
| Est. Completion | 2033-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06777368
The ClinicalTrials.gov registry entry for NCT06777368 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,354-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (83% lower). The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Medtronic TAV is the first listed.
NCT06777368 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT06777368 about?
NCT06777368 is a clinical study titled "REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE". The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
What is the current status of trial NCT06777368?
This trial is currently recruiting. The enrollment target is 225 participants. The study started on 2025-02-06. Estimated completion is 2033-07.
What conditions does trial NCT06777368 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT06777368?
The interventions under investigation include: Medtronic TAV (DEVICE), Edwards TAV (DEVICE).
Who is sponsoring clinical trial NCT06777368?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06777368 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Loss of Y Chromosome in Aortic Stenosis
RECRUITING
-
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RECRUITING · Phase 2
-
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
RECRUITING
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Comparative Imaging Assessment of Valvular Heart Disease
RECRUITING
-
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.